Omran Saifi

Radiation Oncology

4500 San Pablo Rd S
Jacksonville, FL 32224

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractions.

Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractions.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 13, 2026

Safety of concurrent radiation therapy with the antibody-drug conjugate polatuzumab vedotin in relapsed or refractory aggressive B-cell lymphomas.

Safety of concurrent radiation therapy with the antibody-drug conjugate polatuzumab vedotin in relapsed or refractory aggressive B-cell lymphomas.

Journal: Practical radiation oncology

Published: January 07, 2026

Four-dimensional computed tomography in expiratory central airway collapse: Disrupting diagnostic paradigms.

Four-dimensional computed tomography in expiratory central airway collapse: Disrupting diagnostic paradigms.

Journal: European journal of radiology

Published: June 11, 2025

Publication Disparity in Lymphomatous Hematologic Radiation Oncology.

Publication Disparity in Lymphomatous Hematologic Radiation Oncology.

Journal: International journal of radiation oncology, biology, physics

Published: April 10, 2025

The Role of Radiation Therapy in the Management of Gray Zone Lymphoma.

The Role of Radiation Therapy in the Management of Gray Zone Lymphoma.

Journal: International journal of radiation oncology, biology, physics

Published: March 14, 2025

Reduced-Dose Hypofractionated Radiation Therapy (3 Gy × 3 Fractions) for Indolent Non-Hodgkin's lymphoma (POSEIDON): A Multisite Phase 2 Randomized Trial Protocol.

Reduced-Dose Hypofractionated Radiation Therapy (3 Gy × 3 Fractions) for Indolent Non-Hodgkin's lymphoma (POSEIDON): A Multisite Phase 2 Randomized Trial Protocol.

Journal: Advances in radiation oncology

Published: March 12, 2025

Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups.

Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups.

Journal: The Lancet. Haematology

Published: February 20, 2025

Radiation therapy in clinically node positive HER2 positive breast cancer after primary systemic therapy and breast conserving surgery: pooled analysis of TRYPHAENA and NeoSphere trials.

Radiation therapy in clinically node positive HER2 positive breast cancer after primary systemic therapy and breast conserving surgery: pooled analysis of TRYPHAENA and NeoSphere trials.

Journal: BMC cancer

Published: February 19, 2025

Rectal Relief: Proton Therapy's Impact on Urgency and Frequency.

Rectal Relief: Proton Therapy's Impact on Urgency and Frequency.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 30, 2024

Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groups.

Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groups.

Journal: The Lancet. Haematology

Published: June 28, 2024

Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapy.

Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapy.

Journal: Blood advances

Published: May 17, 2024

Comprehensive Bridging Radiotherapy for Limited Pre-CART Non-Hodgkin Lymphoma.

Comprehensive Bridging Radiotherapy for Limited Pre-CART Non-Hodgkin Lymphoma.

Journal: JAMA oncology

Published: May 09, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026